Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 15 studies | 24% ± 8% | |
endothelial cell of lymphatic vessel | 13 studies | 22% ± 5% | |
vein endothelial cell | 9 studies | 24% ± 12% | |
capillary endothelial cell | 4 studies | 22% ± 5% | |
epithelial cell | 4 studies | 19% ± 4% |
Insufficient scRNA-seq data for expression of EPHB4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 7105.90 | 459 / 459 | 99% | 73.38 | 1108 / 1118 |
lung | 100% | 6090.47 | 578 / 578 | 99% | 67.98 | 1144 / 1155 |
esophagus | 100% | 3867.08 | 1444 / 1445 | 99% | 82.91 | 181 / 183 |
intestine | 100% | 3847.51 | 966 / 966 | 98% | 80.04 | 518 / 527 |
uterus | 100% | 11431.04 | 170 / 170 | 98% | 65.33 | 451 / 459 |
prostate | 100% | 6337.60 | 245 / 245 | 98% | 50.96 | 493 / 502 |
stomach | 99% | 3310.40 | 357 / 359 | 99% | 69.59 | 282 / 286 |
pancreas | 100% | 2907.20 | 328 / 328 | 97% | 67.01 | 173 / 178 |
bladder | 100% | 3591.62 | 21 / 21 | 96% | 58.24 | 482 / 504 |
liver | 100% | 3465.07 | 226 / 226 | 96% | 44.04 | 388 / 406 |
skin | 100% | 5514.47 | 1809 / 1809 | 90% | 44.19 | 426 / 472 |
ovary | 100% | 7131.66 | 180 / 180 | 89% | 37.93 | 382 / 430 |
thymus | 100% | 3960.71 | 652 / 653 | 86% | 20.53 | 519 / 605 |
kidney | 100% | 4163.38 | 89 / 89 | 84% | 29.99 | 759 / 901 |
adrenal gland | 100% | 9437.35 | 258 / 258 | 63% | 34.46 | 144 / 230 |
adipose | 100% | 5311.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 9430.18 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 64.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.21 | 1 / 1 |
heart | 97% | 2507.99 | 838 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 15.09 | 63 / 80 |
blood vessel | 63% | 1377.36 | 841 / 1335 | 0% | 0 | 0 / 0 |
brain | 10% | 106.13 | 273 / 2642 | 42% | 10.05 | 297 / 705 |
muscle | 30% | 338.13 | 243 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 30% | 438.54 | 276 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 1.26 | 3 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002042 | Biological process | cell migration involved in sprouting angiogenesis |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0001525 | Biological process | angiogenesis |
GO_0007275 | Biological process | multicellular organism development |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0007155 | Biological process | cell adhesion |
GO_0003007 | Biological process | heart morphogenesis |
GO_0005829 | Cellular component | cytosol |
GO_0043235 | Cellular component | receptor complex |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0005003 | Molecular function | ephrin receptor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
Gene name | EPHB4 |
Protein name | receptor protein-tyrosine kinase (EC 2.7.10.1) Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11) |
Synonyms | HTK MYK1 hCG_20448 TYRO11 tcag7.1248 |
Description | FUNCTION: Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Together with its cognate ligand/functional ligand EFNB2 it is involved in the regulation of cell adhesion and migration, and plays a central role in heart morphogenesis, angiogenesis and blood vessel remodeling and permeability. EPHB4-mediated forward signaling controls cellular repulsion and segregation from EFNB2-expressing cells. . |
Accessions | ENST00000360620.7 ENST00000358173.8 [P54760-1] Q541P7 P54760 ENST00000616502.4 [P54760-3] Q96L35 |